Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001987296 | SCV002207753 | pathogenic | not provided | 2022-03-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CYP19A1-related conditions. This variant is present in population databases (rs752116741, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Leu168Serfs*11) in the CYP19A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP19A1 are known to be pathogenic (PMID: 14602738, 27086564, 27256151). |